These studies have highlighted, for instance, the limited specificity of isolated clinical signs in diagnosing pneumonia [13], and have similarly confirmed that the effectiveness of biomarkers such as CRP and PCT remains moderate when used as standalone indicators [14]. The gene discussed is CRP; the disease is pneumonia.